IP Library Granted Patent US 9,873,707
Granted Patent B2
US 9,873,707 · App. 15/029,876 · Granted Jan 23, 2018

Methods and intermediates for preparing macrolactams

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,873,707
App. No.
15/029,876
Granted
Jan 23, 2018
Kind
B2
Abstract

The present invention includes compounds useful as intermediates in the preparation of macrolactams, methods for preparing the intermediates, and methods for preparing macrolactams. One use of the methods and intermediates described herein is in the production of macrolactam compounds able to inhibit HCV NS3 protease activity. HCV NS3 inhibitory compounds have therapeutic and research applications.

Claims (72)

1. A method of making compounds of Formula C:

wherein n is selected from the group consisting of 0, 1, 2, 3, 4, 5, 6, 7 and 8; X 1 and X 2 are each independently selected from the group consisting of Br, Cl and I; and R 5 is CF 3 ; said method comprising:

(1) reacting

 where LG is selected from the group consisting of halogen atoms, —O—SO 2 R 8 , —O—PO(OR 8 ) 2 and a protecting group and each R 8 is independently selected from the group consisting of C 1-8 alkyl, C 3-8 cycloalkyl, aryl and heteroaryl groups and each R 8 is independently substituted by 0, 1, 2, 3 or 4 substituents independently selected from the group consisting of C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, aryl, halogen, —NH 2 and —OH, and the protecting group is selected from —OSiR 8 and —OR 8 , with a chiral alcohol and

 to produce

 where each R 1 is independently selected from the group consisting of C 1-8 alkyl, aryl and heteroaryl groups, or two R 1 are taken, together with the O—P—O atoms to which they are attached, to form a ring containing 5-19 atoms; and where R 2 and R 3 are each selected from the group consisting of H, C 1-8 alkyl and —O—C 1-8 alkyl groups, or R 2 and R 3 are taken together with the nitrogen atom to which they are attached to form a ring containing 5-19 atoms;

(2) reacting

 with a Grignard reagent to produce

 where R 4 is selected from the group consisting of C 1-8 alkyl, aryl, and heteroaryl groups and R 4 is substituted by 0, 1, 2, 3 or 4 substituents independently selected from the group consisting of C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, aryl, halogen, —NH 2 or —OH;

(3) halogenating

 to produce

 where X 1 and X 2 are each independently selected from the group consisting of Br, Cl and I; and

(4) reacting

 with triflouroacetic anhydride to produce

 where R 5 is CF 3 .

2. A method of making a compound of Formula B:

or a salt thereof, wherein n is selected from the group consisting of 0, 1, 2, 3, 4, 5, 6, 7 and 8; and R 7 is selected from the group consisting of acetyl and

and R 6 is selected from the group consisting of C 1-8 alkyl, C 3-8 cycloalkyl, aryl, and heterocycle groups and R 6 is substituted by 0, 1, 2, 3 or 4 substituents independently selected from the group consisting of C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, aryl, halogen, —NH 2 and —OH, and salts thereof; said method comprising:

preparing a compound of Formula C according to the method of claim 1 ; and

converting

 or a salt thereof.

3. The method of claim 1 , wherein

in step (1) is prepared by:

(i) reacting

 where n is as defined in claim 1 and X is a halogen atom, with a magnesium source to produce

and

(ii) reacting

 with

 to produce

 where LG is defined as in claim 1 .

4. The method of claim 3 , wherein X is Br.

5. The method of claim 2 , wherein said converting

 comprises:

(i) de-halogenating

 to produce

(ii) reacting

 with a reagent containing a leaving group to produce

 where LG is said leaving group and is selected from the group consisting of halogen atoms, —O —SO 2 R 8 , —O —PO(OR 8 ) 2 and a protecting group and each R 8 is independently selected from the group consisting of C 1-8 alkyl, C 3-8 cycloalkyl, aryl, and heteroaryl groups and each R 8 is independently substituted by 0, 1, 2, 3,or 4 substituents independently selected from the group consisting of C 1-6 alky, C 2-6 alkenyl, C 2-6 alkynyl, aryl halogen, —NH 2 , and —OH, and the protecting group is slected from —OSiR 8 and —OR 8 ;

(iii) reacting

 with

 to produce

 wherein R 7 is

and

(iv) optionally forming a salt of

6. The method of claim 2 , wherein R 6 is selected from the group consisting of C 2 C 6 alykl groups.

7. The method of claim 2 , wherein R 6 is tert-butyl.

8. The method of claim 1 , wherein LG is Cl.

9. The method of claim 1 , wherein, in step (1), the chiral alcohol is chlorohydrin.

10. The method of claim 1 , wherein, in step (1),

11. The method of claim 5 , wherein step (iv) comprises forming a salt of the compound, wherein the salt is selected from tert-butylamine salt, dibenzylamine salt, and dicyclohexyl amine salt.

12. The method of claim 2 , wherein the compound of Formula B has the following structural formula:

or a salt thereof, said method comprising:

(1) reacting

 with chlorohydrin and

 to produce

(2) reacting

 with a Grignard reagent to produce

(3) brominating

 to produce

(4) reacting

 with trifluoroacetic anhydride to produce

(5) converting

(6) optionally converting

 to a salt thereof.

13. A method of preparing Compound A:

or a pharmaceutically acceptable salt thereof, said method comprising:

(a) producing a compound of Formula B according to claim 12 ,

(b) reacting

 with

 to produce

 where PG is H or a protecting group selected from —OSiR 8 and —OR 8 ;

(c) and further comprising the steps of:

Assignments (1)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →